FDA recall record

bioMerieux VIDAS Clostridium Difficile GDH, REF 30125-01 recall — FDA Z-0426-2022

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads…

Class IIclassification
Z-0426-2022official record ID
Jan 5, 2022report date

Recall record at a glance

Official recordZ-0426-2022
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmbioMerieux, Inc.
Report dateJan 5, 2022
Recall initiation dateSep 22, 2021
Quantity50
LocationDurham, NC, United States

Official product description

VIDAS Clostridium Difficile GDH, REF 30125-01

Why the product was recalled

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

Distribution information

US Nationwide distribution.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceMay 1, 2024

Biomerieux VITEK 2 - AST Test kits recall — FDA Z-1464-2024

Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for…

Class IFDA: OngoingBiomerieux Inc.